Glyphic Biotechnologies is a company focused on developing technology for proteomics research. They aim to change the future of proteomics through their innovations.

Glyphic Biotechnologies

We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.

Johnson & Johnson Robotics and Digital Solutions

National Institutes of Health

Qiagen

New York State’s Empire State Development Fund

BioTools Innovator

Wing Venture Capital

Artis Ventures (AV)

Axial VC

Cantos

Civilization Ventures

OMX Ventures

OUP (Osage University Partners)

BIO:GLYPHIC

Glyphic Biotechnologies

locale

market

industry

website

linkedin

founding date

investor of

Metrics